Biacore T200 Software v.2.0 from GE Healthcare enhances the capabilities of Biacore T200, offering researchers a tool for efficient processing of molecular interaction data. Together, they facilitate label-free screening of low molecular weight compounds and low abundance proteins, giving detailed binding profiles on molecule-drug candidate mechanisms of action that ultimately assist in earlier lead selection and optimization. The new software is designed to simplify and speed up the generation and transformation of raw label-free interaction data into high-quality information, reducing the time needed for screening and hit validation. Wizards guide assay set up, and options are available for designing custom assays, making Biacore T200 ideal for a multi-user environment. The new software encompasses algorithms for efficient ranking and qualification of binders versus non-binders, and enables comparison of datasets through normalization of sample responses by a number of means. By performing detailed evaluation of a single sample or co-evaluating up to 5000 single-concentration samples from multiple runs, Biacore T200 Software v.2.0 reduces the time required for evaluation of large lead series.
GE Healthcare, 800-526-3593, www.gelifesciences.com/biacoret200software